Clinical Trials Sponsored by Amgen Research (Munich) GmbH

Total 29 results

Amgen Research (Munich) GmbH

Completed

A Phase 1 Multiple Dose Study to Compare the Effects of AMG 223 and Sevelamer HCL (Renagel®)

Healthy Volunteers
Amgen Research (Munich) GmbH

Completed

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL) (BLAST)

B-cell Acute Lymphoblastic Leukemia

Austria, Belgium, France, Germany, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
Amgen Research (Munich) GmbH

Completed

Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL

Non-Hodgkin's Lymphoma, Relapsed

Germany
Amgen Research (Munich) GmbH

Completed

Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer (MT110-101)

Solid Tumors

Germany
Amgen Research (Munich) GmbH

Completed

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

United States, Germany, Austria, Canada, France, Italy, Netherlands
Amgen Research (Munich) GmbH

Completed

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Acute Lymphoblastic Leukemia

United States, United Kingdom, Germany, Spain, France, Italy
Amgen Research (Munich) GmbH

Completed

Study of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)

B-ALL

Germany
Amgen Research (Munich) GmbH

Completed

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Diffuse Large B-cell Lymphoma

Germany
Amgen Research (Munich) GmbH

Completed

Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

Acute Lymphoblastic Leukemia

Germany
Amgen Research (Munich) GmbH

Completed

Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases (MT201-204)

Colorectal Cancer | Liver Metastases

Germany, France
Ludwig-Maximilians - University of Munich
Amgen; ClinAssess GmbH

Not yet recruiting

Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation

Treatment Related Cancer

Germany
AIO-Studien-gGmbH
Amgen; Assign Data Management and Biostatistics GmbH; Assign Clinical Research...

Terminated

Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer (POWER)

Esophageal Squamous Cell Cancer

Germany
Technical University of Munich
Gilead Sciences; MUC Research GmbH

Completed

Changes in Insulin Resistance in Healthy Volunteers on STRIBILD® Medication

Insulin Resistance

Germany
Cantonal Hospital of St. Gallen
Celgene Corporation; Amgen; Mundipharma Medical Company; Mundipharma Research GmbH...

Completed

Bendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line Therapy for Patients With Relapsed or Refractory Multiple Myeloma (BRd)

Multiple Myeloma

Switzerland
Prof. Dr. Wolfgang Hiddemann
Hoffmann-La Roche; Mundipharma Research GmbH & Co KG

Completed

First Line Therapy of Advanced Stage Follicular Lymphoma in Patients < 60 Years Not Eligible fo Standard Immunochemotherapy and in All Patients ≥ 60 Years (GABe2016)

Indolent Non-hodgkin Lymphoma

Germany
Institut für Klinisch-Kardiovaskuläre Forschung...
AstraZeneca; Boehringer Ingelheim; Amgen; Sanofi-Aventis Deutschland GmbH; BMBf (Federal... and other collaborators

Unknown

Coronary Artery Disease and Renal Failure Registry (CAD-REF)

Coronary Artery Disease | Renal Failure

Germany
Deutsches Herzzentrum Muenchen
German Federal Ministry of Education and Research; Technical University of... and other collaborators

Completed

Intracoronary Stenting and Antithrombotic Regimen: Lesion Platelet Adhesion as Selective Target of Endovenous Revacept (ISAR-PLASTER)

Stable Coronary Artery Disease

Germany
Beth Israel Deaconess Medical Center
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Study of Leptin for the Treatment of Hypothalamic Amenorrhea

Amenorrhea

United States
Universitätsklinikum Hamburg-Eppendorf
Ludwig-Maximilians - University of Munich; Philipps University Marburg Medical... and other collaborators

Completed

Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-ST Against COVID-19 (MVA-SARS2-ST)

Covid19

Germany
Technical University of Munich
Paracelsus Medical University; Ludwig Boltzmann Institute for Digital Health... and other collaborators

Recruiting

Connect2Move: Valorization of Natural Cardio Trekking Hiking Trails (Connect2Move)

Healthy | Healthy Lifestyle | Cardiovascular Prevention

Germany
German Institute of Human Nutrition
Charite University, Berlin, Germany; University of Southern California; German... and other collaborators

Completed

NUtriGenomic Analysis in Twins (NUGAT)

Metabolic Response to Dietary Modification

Germany
Schön Klinik Berchtesgadener Land
GlaxoSmithKline GmbH & Co. KG (Munich, Germany); Coordinating Center for Clinical... and other collaborators

Recruiting

Predictors of Acute Exacerbation in Patients With COPD - an Observational Study (PACE)

Chronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | COPD Exacerbation Acute

Germany
AIO-Studien-gGmbH
Bristol-Myers Squibb; Eli Lilly and Company; Merck Sharp & Dohme LLC; Pfizer; Gilead... and other collaborators

Recruiting

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients (CRISP)

Small-cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage I | Metastatic Non-small Cell Lung Cancer (NSCLC) | Non Small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer Stage II

Germany
Michael Hoelscher
Karolinska Institutet; University of Stellenbosch; University of Cape Town Lung... and other collaborators

Completed

Rapid and Accurate Diagnosis of Paediatric TB (RaPaed-AIDA-TB) (RaPaed)

Tuberculosis | Diagnoses Disease

India, Mozambique, Tanzania, Malawi, South Africa
Michael Hoelscher
German Federal Ministry of Education and Research; ANRS, Emerging Infectious... and other collaborators

Completed

A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen (FATI-01)

HIV-1 Infection

Côte D'Ivoire, Tanzania
National Institute of Diabetes and Digestive and...
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Completed

ATG-GCSF in New Onset Type 1 Diabetes (ATG-GCSF)

Diabetes Mellitus, Type 1

United States
Mats Heyman
Assistance Publique - Hôpitaux de Paris; Karolinska Institutet; Pfizer; The Swedish... and other collaborators

Recruiting

A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

Leukemia, Acute Lymphoblastic

Belgium, United Kingdom, Denmark, Germany, Portugal, Netherlands, Estonia, France, Finland, Iceland, Norway, Sweden, Lithuania, Ireland
Medical University of Vienna
Odense University Hospital; Karolinska Institutet; The University of Texas Health... and other collaborators

Completed

Meta-Analysis of Cell-based CaRdiac stUdiEs: ACCRUE (ACCRUE)

Ischemic Heart Disease

Austria
Center for Sepsis Control and Care, Germany
Hannover Medical School; German Federal Ministry of Education and Research; University... and other collaborators

Completed

Quality Improvement in Infection COntrol and Sepsis Management in MOdel Regions (icosmos)

Sepsis | Septic Shock | Severe Sepsis

Germany

Clinical Trials Sponsored by Amgen Research (Munich) GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations